Skip to main content
. 2012 May 17;107(1):100–107. doi: 10.1038/bjc.2012.216

Table 2. Validation cohort characteristics.

Number 58
Mean age 61
Mean PSA 6.9
Mean follow-up (months) 57
Gleason
 3+3 11 (19%)
 3+4 35 (60%)
 4+3 8 (14%)
 4+4 1 (2%)
 4+5 3 (5%)
   
Stage
 T2 2
 T2a 1
 T2b 44
 T3a 8
 T3b 3
PSA recurrence 14 (24%)
Lymph nodes (+) 40 (69%)
Surgical margins (+) 5 (9%)
Extracapsular extension 11 (19%)
Seminal vesicle (+) 4 (7%)
Hypermethylated tumour 46 (83%)